More than 4 decades of expertise in innovative technologies and value-added pharmaceutical solutions. Procaps Group's purpose is to spread its legacy and improve healthcare once and for all.
- Sofgen Pharmaceuticals obtains Drug Establishment License
- Learn all about Procaps Group participation at CPhI FRANKFURT 2022
- Discover the endless opportunities our Softgel Capsule can offer to your brand.
- Procaps Group Acquires 1st U.S.-Based Softgel Production Facility under the name Sofgen Pharmaceuticals, expanding its iCDMO Business Unit.